• Amrita Bhat, Gh Rasool Bhat, Sonali Verma, Ruchi Shah, Ashna Nagpal, Bhanu Sharma, Divya Bakshi, Jyotsna Suri, Supinder Singh, Mukesh Tanwar, Samantha Vaishnavi, Audesh Bhat, and Rakesh Kumar.
• Cancer Genetics Research Group, School of Biotechnology, Shri Mata Vaishno Devi University, Katra, J&K, India,182320.
• Afr Health Sci. 2021 Sep 1; 21 (3): 124312491243-1249.

BackgroundThe role of single nucleotide polymorphism rs10937405 (C>T) of the TP63 gene in cancer including leukemia has previously been studied in different world populations; however, the role of this variant in leukemia in the North Indian population of Jammu and Kashmir is still unknown.ObjectivesIn the present study, we investigated the association of genetic variant rs10937405 with leukemic in the Jammu and Kashmir population.MethodsA total of 588 subjects, (188 cases and 400 controls) were recruited for the study. The rs10937405 variant was genotyped by using the real-time based TaqMan assay.ResultsA statistically significant association was observed between the rs10937405 and leukemia [OR of 1.94 (95% CI 1.51-2.48), p=1.2x10-6].ConclusionThe current study concludes that the rs10937405 variant is a risk factor for the development of leukemia in the population of Jammu and Kashmir, North India. However, it would be interesting to explore the contribution of this variant in other cancers as well. Our findings will help in the development of diagnostic markers for leukemia in the studied population and potentially for other North Indian populations.© 2021 Bhat A et al.

18 keywords...

hide…